While the risk of initiating TNF-α inhibitors (adjusted IRR: 0.56, 95% CI: 0.32–1.00) and IBD-related surgery (adjusted IRR: 0.79, 95% CI: 0.57–1.09) was also reduced, these associations were not statistically significant. This evidence concerns the gene TNF and inflammatory bowel disease.